Applications of AI in Drug Discovery
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

Applications of AI in Drug Discovery

Willie Martin, Director, Discovery Process, Alkermes

Willie Martin, Director, Discovery Process, Alkermes

Drug design software using machine learning and deep learning features aids in the discovery of new molecular targets.

The primary goal of drug discovery is to find treatments that can prevent and treat the condition in question. Metabolomics has provided several new insights into medical research. The majority of the medications are made up of small chemically synthesized molecules. These bind to the disordered molecule's target molecule. Moreover, this target molecule is almost always a protein. The identification of these molecules, on the other hand, has historically relied on the study of massive library screens. It was also followed by the detection of a possible chemical and additional testing.

Artificial Intelligence Application in Drug Discovery

Drug Repurposing

Drug repurposing also benefits from the identification of molecular drug interactions. Drugs not only engage with the target molecules but also with other molecules. As a result, existing drugs can be used to treat diseases that have no cure. Drug design software using machine learning and deep learning features aids in the discovery of new molecular targets. Furthermore, examining the drug's interactions with off-target molecules aids in the discovery of new possibilities. It also serves as a link between drug research and implementation in clinical practice.

Clinical Trials

Clinical studies consume a significant amount of time during the drug development process. Manual data analysis and monitoring take time. Furthermore, there is the possibility of human error. As a result, medication failure may occur. Artificial Intelligence (AI) algorithms can process large amounts of data while also providing reliable findings in a short amount of time. Clinical trial costs can be reduced thanks to artificial intelligence. Furthermore, it improves patient compliance. Clinical trials with AI ensure that drug effects are quickly identified. Moreover, it supports treatments with scientific proof.

Target Identification

Identification of molecules such as genes and proteins is included in the definition of molecular target identification. AI and machine learning-based drug discovery software aids in the examination of molecules. Furthermore, data mining tools for drug discovery aids in target prediction and prioritization.

Researchers have benefited from AI's assistance in analyzing massive amounts of data. Furthermore, drug design software has allowed researchers to extract information from massive datasets. Previously, AI software for drug development was limited to DNA and RNA analysis. Now, drug discovery software may use computer vision to analyze proteins further and categorize molecules.

See Also :- Top Manufacturing Technology Solution Companies
 

Weekly Brief

Top 10 Drug Discovery and Development Solution Companies - 2020
Top 10 Drug Discovery and Development Consulting/Service Companies - 2020

Read Also

What the New EMA Draft

What the New EMA Draft "Guideline on Computerized Systems and Electronic Data" Means to Your Systems

Cathlin Shapiro, Parexel, Director, Technology Quality Assurance
How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

Stewart Campbell, VP & General Manager at West Pharmaceutical & Li Chen, VP & General Manager at West Pharmaceutical
Optimizing Alkermes' R&D Model for Success

Optimizing Alkermes' R&D Model for Success

Craig Hopkinson, M.D., CMO and Executive Vice President, Research and Development, Alkermes
Impact of Advanced Manufacturing Technologies on the Pharmaceutical Industry

Impact of Advanced Manufacturing Technologies on the Pharmaceutical Industry

Atul Dubey, Director, Pharmaceutical Continuous Manufacturing, US Pharmacopeia
European Compliance Tech

European Compliance Tech

Bennett Lau, Compliance Officer, Gr├╝nenthal
How Technology Enhances the Effectiveness of Compliance Programs

How Technology Enhances the Effectiveness of Compliance Programs

Patrik Florencio, SVP and Chief Compliance & Risk Officer, and Michael Schneider, Executive Director, Global ERM and Compliance Auditing, Amicus Therapeutics